Belsons is a pharmaceutical company that manufactures Abiraterone Acetate 250mg Tablets, a medication used for treating prostate cancer. Abiraterone acetate tablets are a type of hormonal therapy that works by blocking the production of testosterone, a hormone that can stimulate the growth of prostate cancer cells. Prostate cancer is a common type of cancer in men, with a high survival rate if detected early. However, for some men, the cancer can become more aggressive and resistant to traditional treatments. This is where medications like Abiraterone Acetate 250mg Tablets come into play. Abiraterone acetate tablets are typically prescribed to men with advanced prostate cancer that has spread to other parts of the body, known as metastatic prostate cancer. The medication is often used in combination with other treatments, such as steroids or chemotherapy, to help slow down the progression of the cancer and improve the patient's quality of life. One of the key benefits of Abiraterone Acetate 250mg Tablets is that they target a specific enzyme called CYP17, which is involved in the production of testosterone.